179 related articles for article (PubMed ID: 32757799)
21. Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.
Boudhabhay I; Rabant M; Roumenina LT; Coupry LM; Poillerat V; Marchal A; Frémeaux-Bacchi V; El Karoui K; Monchi M; Pourcine F
Front Immunol; 2021; 12():680567. PubMed ID: 34248962
[TBL] [Abstract][Full Text] [Related]
22. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
[TBL] [Abstract][Full Text] [Related]
23. [Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report].
Rogier T; Gerfaud-Valentin M; Pouteil-Noble C; Taleb A; Guillet M; Noel A; Broussolle C; Sève P
Rev Med Interne; 2016 Oct; 37(10):701-704. PubMed ID: 26833144
[TBL] [Abstract][Full Text] [Related]
24. Eculizumab in secondary atypical haemolytic uraemic syndrome.
Cavero T; Rabasco C; López A; Román E; Ávila A; Sevillano Á; Huerta A; Rojas-Rivera J; Fuentes C; Blasco M; Jarque A; García A; Mendizabal S; Gavela E; Macía M; Quintana LF; María Romera A; Borrego J; Arjona E; Espinosa M; Portolés J; Gracia-Iguacel C; González-Parra E; Aljama P; Morales E; Cao M; Rodríguez de Córdoba S; Praga M
Nephrol Dial Transplant; 2017 Mar; 32(3):466-474. PubMed ID: 28339660
[TBL] [Abstract][Full Text] [Related]
25. Case Report: Carfilzomib-induced Thrombotic Microangiopathy With Complement Activation Treated Successfully With Eculizumab.
Bhutani D; Assal A; Mapara MY; Prinzing S; Lentzsch S
Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):e155-e157. PubMed ID: 32098724
[No Abstract] [Full Text] [Related]
26. Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.
Jodele S; Dandoy CE; Danziger-Isakov L; Myers KC; El-Bietar J; Nelson A; Wallace G; Teusink-Cross A; Davies SM
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1337-1340. PubMed ID: 27060440
[TBL] [Abstract][Full Text] [Related]
27. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
Jodele S; Dandoy CE; Lane A; Laskin BL; Teusink-Cross A; Myers KC; Wallace G; Nelson A; Bleesing J; Chima RS; Hirsch R; Ryan TD; Benoit S; Mizuno K; Warren M; Davies SM
Blood; 2020 Mar; 135(13):1049-1057. PubMed ID: 31932840
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease.
Bhunia N; Abu-Arja R; Bajwa RPS; Auletta JJ; Rangarajan HG
Pediatr Blood Cancer; 2019 Oct; 66(10):e27912. PubMed ID: 31264793
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of acute thrombotic microangiopathy by eculizumab after combined lung and kidney transplantation.
Commereuc M; Karras A; Amrein C; Boussaud V; Sberro-Soussan R; Guillemain R; Bacchi VF; Thervet E
Transplantation; 2013 Oct; 96(8):e58-9. PubMed ID: 24132114
[No Abstract] [Full Text] [Related]
30. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.
Shochet L; Kanellis J; Simpson I; Ta J; Mulley W
Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480
[TBL] [Abstract][Full Text] [Related]
31. Thrombotic microangiopathy associated with intravenous injection of extended-release oxycodone.
Robson KJ; Clucas D; Filshie R; Nandurkar H
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28716778
[TBL] [Abstract][Full Text] [Related]
32. Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma.
Rassner M; Baur R; Wäsch R; Schiffer M; Schneider J; Mackensen A; Engelhardt M
BMC Nephrol; 2021 Jan; 22(1):32. PubMed ID: 33461512
[TBL] [Abstract][Full Text] [Related]
33. When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies.
Olson SR; Lu E; Sulpizio E; Shatzel JJ; Rueda JF; DeLoughery TG
Am J Nephrol; 2018; 48(2):96-107. PubMed ID: 30110670
[TBL] [Abstract][Full Text] [Related]
34. Thrombotic Microangiopathy in a Patient Treated With Gemcitabine.
Nanjappa S; Singh V; Uttamchandani S; Pabbathi S
Cancer Control; 2017 Jan; 24(1):54-56. PubMed ID: 28178713
[TBL] [Abstract][Full Text] [Related]
35. Eculizumab in Transplant-Associated Thrombotic Microangiopathy.
Dhakal P; Giri S; Pathak R; Bhatt VR
Clin Appl Thromb Hemost; 2017 Mar; 23(2):175-180. PubMed ID: 26259912
[TBL] [Abstract][Full Text] [Related]
36. Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature.
Skoczynska M; Crowther MA; Chowaniec M; Ponikowska M; Chaturvedi S; Legault K
Lupus; 2020 May; 29(6):631-639. PubMed ID: 32252584
[No Abstract] [Full Text] [Related]
37. Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome.
Geethakumari PR; Mille P; Gulati R; Nagalla S
Transfus Apher Sci; 2017 Jun; 56(3):400-403. PubMed ID: 28428030
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab.
Wilson CH; Brown AL; White SA; Goodship TH; Sheerin NS; Manas DM
Transplantation; 2011 Oct; 92(8):e42-3. PubMed ID: 21989273
[No Abstract] [Full Text] [Related]
39. Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab.
Iqbal Z; Wood K; Carter V; Goodship TH; Brown AL; Sheerin NS
Transplant Proc; 2015 Sep; 47(7):2258-61. PubMed ID: 26361694
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis.
Zhang R; Zhou M; Qi J; Miao W; Zhang Z; Wu D; Han Y
Front Immunol; 2020; 11():564647. PubMed ID: 33552043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
